NCT03625258 (HEPATITEB) is a clinical trial in Hepatitis B Virus, sponsored by Centre Hospitalier Universitaire, Amiens.

Who is sponsoring NCT03625258?

NCT03625258 is sponsored by Centre Hospitalier Universitaire, Amiens.

What condition does NCT03625258 study?

NCT03625258 studies Hepatitis B Virus.

Is NCT03625258 still recruiting?

NCT03625258 is currently completed. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT03625258: HEPATITEB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mutations of the Pre-core Region of Hepatite B Virus (HBV)

Completed Last updated 17 May 2023

What this trial tests

trial in Hepatitis B Virus in 200 participants. Completed in 1 February 2017.

Timeline

1 January 2009

Primary endpoint
1 February 2017

1 February 2017

Quick facts

Lead sponsor	Centre Hospitalier Universitaire, Amiens
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 January 2009
Primary completion	1 February 2017
Estimated completion	1 February 2017

Conditions studied

Hepatitis B Virus — all drugs for Hepatitis B Virus →

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Hepatitis B Virus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hepatitis B virus (HBV) infection constitutes a major public health threat worldwide. A total of 92 patients with HBeAg-negative chronic hepatitis B infection were recruited at Amiens University Hospital. The diagnostic workup included a physical examination.In conclusion, the study results confirmed that the HBV DNA level is associated with liver fibrosis status and that HBV viral load is strongly correlated with BCP and PC mutations, and it demonstrated that the impaired base pairing 1858-1896 mutations at the base of the bulge in the e encapsidation signal is independently associated with high serum HBV DNA levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hepatitis B Virus

Currently open trials in the same condition.

NCT06881238 — Impact of Hepatitis B Virus on Inflammatory Bowel Disease · recruiting
NCT04231565 — Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA. · NA · recruiting

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
NCT07071662 — Induction of Labor in Breech Presentation · completed
NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03625258 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03625258.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing